October 2022 Medical News Summary

<p>Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.11489?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13668?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Treating Cancer in Pregnant Patients After Roe v Wade Overturned</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13662?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Dobbs Decision Threatens Full Breadth of Ob-Gyn Training</a></li> </ul>